Literature DB >> 30955896

Nature-Derived Peptides: A Growing Niche for GPCR Ligand Discovery.

Edin Muratspahić1, Michael Freissmuth2, Christian W Gruber3.   

Abstract

G protein-coupled receptors (GPCRs) represent important drug targets, as they regulate pivotal physiological processes and they have proved to be readily druggable. Natural products have been and continue to be amongst the most valuable sources for drug discovery and development. Here, we surveyed small molecules and (poly-)peptides derived from plants, animals, fungi, and bacteria, which modulate GPCR signaling. Among naturally occurring compounds, peptides from plants, cone-snails, snakes, spiders, scorpions, fungi, and bacteria are of particular interest as lead compounds for the development of GPCR ligands, since they cover a chemical space, which differs from that of synthetic small molecules. Peptides, however, face challenges, some of which can be overcome by studying plant-derived compounds. We argue here that the opportunities outweigh the challenges.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  animal venom; drug discovery; ligand design; natural product; peptide; plant

Mesh:

Substances:

Year:  2019        PMID: 30955896      PMCID: PMC6624132          DOI: 10.1016/j.tips.2019.03.004

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  121 in total

1.  Muscarinic toxin-like proteins from cobra venom.

Authors:  V V Kukhtina; C Weise; T A Muranova; V G Starkov; P Franke; F Hucho; S Wnendt; C Gillen; V I Tsetlin; Y N Utkin
Journal:  Eur J Biochem       Date:  2000-12

2.  Two new classes of conopeptides inhibit the alpha1-adrenoceptor and noradrenaline transporter.

Authors:  I A Sharpe; J Gehrmann; M L Loughnan; L Thomas; D A Adams; A Atkins; E Palant; D J Craik; D J Adams; P F Alewood; R J Lewis
Journal:  Nat Neurosci       Date:  2001-09       Impact factor: 24.884

Review 3.  The sarafotoxins.

Authors:  Frédéric Ducancel
Journal:  Toxicon       Date:  2002-11       Impact factor: 3.033

Review 4.  Seven-transmembrane receptors.

Authors:  Kristen L Pierce; Richard T Premont; Robert J Lefkowitz
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

5.  A family of depsi-peptide fungal metabolites, as selective and competitive human tachykinin receptor (NK2) antagonists: fermentation, isolation, physico-chemical properties, and biological activity.

Authors:  V R Hedge; M S Puar; P Dai; H Pu; M Patel; J C Anthes; C Richard; J Terracciano; P R Das; V Gullo
Journal:  J Antibiot (Tokyo)       Date:  2001-02       Impact factor: 2.649

6.  Rubiscolin, a delta selective opioid peptide derived from plant Rubisco.

Authors:  S Yang; J Yunden; S Sonoda; N Doyama; A W Lipkowski; Y Kawamura; M Yoshikawa
Journal:  FEBS Lett       Date:  2001-12-07       Impact factor: 4.124

7.  Muscarinic toxin-like proteins from Taiwan banded krait (Bungarus multicinctus) venom: purification, characterization and gene organization.

Authors:  Charling Chung; Bin-Nan Wu; Chen-Chung Yang; Long-Sen Chang
Journal:  Biol Chem       Date:  2002-09       Impact factor: 3.915

8.  Kinestatin: a novel bradykinin B2 receptor antagonist peptide from the skin secretion of the Chinese toad, Bombina maxima.

Authors:  Tianbao Chen; Martin O'Rourke; David F Orr; Daniel J M Coulter; David G Hirst; Pingfan Rao; Chris Shaw
Journal:  Regul Pept       Date:  2003-11-15

9.  Contulakin-G, an O-glycosylated invertebrate neurotensin.

Authors:  A G Craig; T Norberg; D Griffin; C Hoeger; M Akhtar; K Schmidt; W Low; J Dykert; E Richelson; V Navarro; J Mazella; M Watkins; D Hillyard; J Imperial; L J Cruz; B M Olivera
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

10.  CJ-15,208, a novel kappa opioid receptor antagonist from a fungus, Ctenomyces serratus ATCC15502.

Authors:  Toshiyuki Saito; Hideo Hirai; Yoon-Jeong Kim; Yasuhiro Kojima; Yasue Matsunaga; Hiroyuki Nishida; Tatsuo Sakakibara; Osamu Suga; Tetsujo Sujaku; Nakao Kojima
Journal:  J Antibiot (Tokyo)       Date:  2002-10       Impact factor: 2.649

View more
  15 in total

1.  Structure and selectivity engineering of the M1 muscarinic receptor toxin complex.

Authors:  Shoji Maeda; Jun Xu; Francois Marie N Kadji; Mary J Clark; Jiawei Zhao; Naotaka Tsutsumi; Junken Aoki; Roger K Sunahara; Asuka Inoue; K Christopher Garcia; Brian K Kobilka
Journal:  Science       Date:  2020-07-10       Impact factor: 47.728

2.  Evaluating functional ligand-GPCR interactions in cell-based assays.

Authors:  Sheryl Sharma; James W Checco
Journal:  Methods Cell Biol       Date:  2021-07-29       Impact factor: 1.441

Review 3.  Neuropeptide signalling systems - An underexplored target for venom drug discovery.

Authors:  Helen C Mendel; Quentin Kaas; Markus Muttenthaler
Journal:  Biochem Pharmacol       Date:  2020-06-30       Impact factor: 5.858

Review 4.  Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products.

Authors:  Dongchen An; Steve Peigneur; Louise Antonia Hendrickx; Jan Tytgat
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

5.  Functional GLP-1R antibodies identified from a synthetic GPCR-focused library demonstrate potent blood glucose control.

Authors:  Qiang Liu; Pankaj Garg; Burcu Hasdemir; Linya Wang; Emily Tuscano; Emily Sever; Erica Keane; Ana G Lujan Hernandez; Tom Z Yuan; Eric Kwan; Joyce Lai; Greg Szot; Sreenivasan Paruthiyil; Fumiko Axelrod; Aaron K Sato
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

Review 6.  G protein-coupled receptors: structure- and function-based drug discovery.

Authors:  Dehua Yang; Qingtong Zhou; Viktorija Labroska; Shanshan Qin; Sanaz Darbalaei; Yiran Wu; Elita Yuliantie; Linshan Xie; Houchao Tao; Jianjun Cheng; Qing Liu; Suwen Zhao; Wenqing Shui; Yi Jiang; Ming-Wei Wang
Journal:  Signal Transduct Target Ther       Date:  2021-01-08

Review 7.  Cyclic peptide drugs approved in the last two decades (2001-2021).

Authors:  Huiya Zhang; Shiyu Chen
Journal:  RSC Chem Biol       Date:  2021-11-05

8.  Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds that Targets the κ-Opioid Receptor for the Treatment of Chronic Abdominal Pain.

Authors:  Edin Muratspahić; Nataša Tomašević; Johannes Koehbach; Leopold Duerrauer; Seid Hadžić; Joel Castro; Gudrun Schober; Spyridon Sideromenos; Richard J Clark; Stuart M Brierley; David J Craik; Christian W Gruber
Journal:  J Med Chem       Date:  2021-06-23       Impact factor: 7.446

Review 9.  Natural Compounds as Guides for the Discovery of Drugs Targeting G-Protein-Coupled Receptors.

Authors:  Joan Serrano-Marín; Irene Reyes-Resina; Eva Martínez-Pinilla; Gemma Navarro; Rafael Franco
Journal:  Molecules       Date:  2020-10-30       Impact factor: 4.411

Review 10.  Inhibition of Viral Membrane Fusion by Peptides and Approaches to Peptide Design.

Authors:  Nejat Düzgüneş; Narcis Fernandez-Fuentes; Krystyna Konopka
Journal:  Pathogens       Date:  2021-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.